Pharmaceutical Science To Improve The Human Condition
This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Bro Bono Humanitarian Awards (. The Prix Galien was created in France by pharmacist Roland Mehl, whose aim was to promote the country’s significant advances in pharmaceutical research.
The Prix Galien USA recognizes excellence in biopharmaceutical research and development that can make significant improvements in the human condition. This Annals volume presents the scientific achievements by winners and finalists of the 2012 Prix Galien USA. Contributions include scholarly summaries from biopharmaceutical industry leaders (GlaxoSmithKline, MethylGene, Bristol-Myers Squibb, Novartis, Optimer Pharmaceuticals, Janssen, Bayer, Merck, UCB Pharma, Medtronic, and Novocure) on pharmaceutical advances in the treatment of a wide range of diseases including advanced melanoma, C.